Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Perspective Therapeutics, Inc. to Present at Upcoming Investor Conferences in New York and Florida Quiver Quantitative, Inc. - Wed Nov 27, 4:16PM CST

Perspective Therapeutics announces senior leadership participation in upcoming investor conferences focused on their cancer treatment technologies.Quiver AI SummaryPerspective Therapeutics, Inc. announced...

CATX : 2.85 (+0.35%)
Insider Purchase: Director at $CATX (CATX) Buys 3,647 Shares Quiver Quantitative, Inc. - Wed Nov 27, 4:16PM CST

Robert F III Williamson, a director at $CATX ($CATX), bought 3,647 shares of the company on 11-25-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

CATX : 2.85 (+0.35%)
Perspective Therapeutics to Participate in Upcoming Investor Conferences in December GlobeNewswire - Wed Nov 27, 6:00AM CST

CATX : 2.85 (+0.35%)
Insider Purchase: CEO of $CATX (CATX) Buys 6,600 Shares Quiver Quantitative, Inc. - Tue Nov 26, 4:16PM CST

Johan M. Spoor, the CEO of $CATX ($CATX), bought 6,600 shares of the company on 11-25-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

CATX : 2.85 (+0.35%)
Perspective Therapeutics, Inc. Reports Positive Initial Results from Phase 1/2a Trial of [212Pb]VMT-α-NET for Neuroendocrine Tumors Quiver Quantitative, Inc. - Thu Nov 21, 4:48PM CST

[212Pb]VMT-α-NET shows safety and anti-tumor activity in initial trial results, prompting plans for dose escalation.Quiver AI SummaryPerspective Therapeutics, Inc. announced promising early results from...

CATX : 2.85 (+0.35%)
Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium GlobeNewswire - Thu Nov 21, 6:15AM CST

CATX : 2.85 (+0.35%)
Perspective Therapeutics, Inc. to Present Initial Results of [212Pb]VMT-α-NET Phase 1/2a Trial at NANETS Symposium Quiver Quantitative, Inc. - Sat Nov 16, 1:20AM CST

Perspective Therapeutics will present Phase 1/2a trial results for [212Pb]VMT-α-NET at the NANETS symposium on November 22, 2024.Quiver AI SummaryPerspective Therapeutics, Inc. announced details of an...

CATX : 2.85 (+0.35%)
Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024 GlobeNewswire - Fri Nov 15, 3:08PM CST

CATX : 2.85 (+0.35%)
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results GlobeNewswire - Tue Nov 12, 3:05PM CST

CATX : 2.85 (+0.35%)
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results GlobeNewswire - Thu Oct 31, 6:00AM CDT

CATX : 2.85 (+0.35%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot